Subscription of New Ord.Shrs

Deltex Medical Group PLC
1 April 2003

1 April 2003


          Deltex Medical Group plc ('Deltex Medical' or the 'Company')

                  Subscription of New Ordinary Shares for Cash

Deltex Medical announces that it has received firm subscriptions from various
institutional and other investors and the Directors in respect of 11,642,570 new
ordinary shares at 7p per share, representing approximately £815,000 (the '
Subscription').  The net proceeds of the Subscription will be used by the
Company as additional working capital to further expand the Group's penetration
in the UK market, in particular in hospital operating theatres, as well as to
develop the Group's business in overseas markets.

In order to demonstrate their confidence in the Group's prospects, the Directors
are participating as investors in the Subscription as follows:

                                                                    Following the              Following the
                                                                     Subscription               Subscription

                                               Number of               Holding of                % of issued
Name of Director                     subscription shares                   shares             share capital*

Nigel Keen                                     2,142,857                2,862,544                       5.20
Nigel Keen (1)                                         -                  589,700                       1.07
Andy Hill                                         42,857                   42,857                       0.08
Ewan Phillips                                    285,714                  365,714                       0.66
Daniel Bretonneau                                142,857                  142,857                       0.26
Edwin Snape (2)                                2,285,714                2,879,925                       5.23
Kempton Coady                                     18,000                   58,000                       0.11
George Flouty                                     64,285                  134,285                       0.24
Peter Smedvig (3)                                186,000                  664,478                       1.21

(1)   as trustee and executor of the Pauline Thomas Charity Will Trust
(2)   as principal of NEGF II L.P. and New England Partners Capital L.P.
(3)   as director of Peder Smedvig Capital AS
*     assuming subscription in full and that no warrants or options are
      exercised

The Company reserves the right to receive further subscriptions at 7p per share
for up to 6,214,573 new ordinary shares (representing up to approximately
£435,000) from investors (resulting in a total fundraising of £1.25 million
(before expenses) assuming subscription in full) during the period ending no
later than 30 April 2003.  These shares are not being offered to existing
shareholders due to the costs and regulatory burden associated with a
pre-emptive offering.

Completion of the Subscription will be conditional upon, among other matters:

(a)   admission of the new ordinary shares to be issued pursuant to the
Subscription to trading on AIM; and

(b)   approval of the Subscription at an extraordinary general meeting of the
Company to be held on 24 April 2003.

Application will be made for the 11,642,570 new ordinary shares to be admitted
to trading on AIM.  Admission is expected to become effective on 25 April 2003.

Enquiries

Deltex Medical Group plc

Nigel Keen, Chairman
[e-mail]
01243 774 837

Andy Hill, Chief Executive
[e-mail]
01243 774 837

Ewan Phillips, Finance Director
[e-mail]
01243 774 837

Financial Dynamics

Stephanie Highett/Francetta Carr
[e-mail]
020 7831 3113


                      This information is provided by RNS
            The company news service from the London Stock Exchange